Literature DB >> 12542474

The role of hydroxyurea in sickle cell disease.

Christina Halsey1, Irene A Roberts.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12542474     DOI: 10.1046/j.1365-2141.2003.03849.x

Source DB:  PubMed          Journal:  Br J Haematol        ISSN: 0007-1048            Impact factor:   6.998


× No keyword cloud information.
  20 in total

Review 1.  Hydroxyurea for children with sickle cell disease.

Authors:  Matthew M Heeney; Russell E Ware
Journal:  Hematol Oncol Clin North Am       Date:  2010-02       Impact factor: 3.722

Review 2.  [Genetic causes of impaired wound healing. Rare differential diagnosis of the non-healing wound].

Authors:  K Elsharkawi-Welt; J Hepp; K Scharffetter-Kochanek
Journal:  Hautarzt       Date:  2008-11       Impact factor: 0.751

3.  AKAP-dependent modulation of BCAM/Lu adhesion on normal and sickle cell disease RBCs revealed by force nanoscopy.

Authors:  Jamie L Maciaszek; Biree Andemariam; Krithika Abiraman; George Lykotrafitis
Journal:  Biophys J       Date:  2014-03-18       Impact factor: 4.033

4.  Potential of Three Ethnomedicinal Plants as Antisickling Agents.

Authors:  Ismaila O Nurain; Clement O Bewaji; Jarrett S Johnson; Robertson D Davenport; Yang Zhang
Journal:  Mol Pharm       Date:  2016-12-05       Impact factor: 4.939

5.  Associations of transcranial doppler velocity, age, and gender with cognitive function in children with sickle cell anemia in Nigeria.

Authors:  Kemar V Prussien; Auwal Salihu; Shehu U Abdullahi; Najibah A Galadanci; Khadija Bulama; Raymond O Belonwu; Fenella J Kirkham; Janet Yarboi; Heather Bemis; Michael R DeBaun; Bruce E Compas
Journal:  Child Neuropsychol       Date:  2018-10-01       Impact factor: 2.500

Review 6.  Hydroxyurea: The drug of choice for polycythemia vera and essential thrombocythemia.

Authors:  David Dingli; Ayalew Tefferi
Journal:  Curr Hematol Malig Rep       Date:  2006-06       Impact factor: 3.952

7.  Smartphone-based sickle cell disease detection and monitoring for point-of-care settings.

Authors:  Shazia Ilyas; Mazhar Sher; E Du; Waseem Asghar
Journal:  Biosens Bioelectron       Date:  2020-07-09       Impact factor: 10.618

8.  A retrospective analysis of the cost of hospitalizations for sickle cell disease with crisis in England, 2010/11.

Authors:  E Pizzo; A A Laverty; K J Phekoo; G AlJuburi; S A Green; D Bell; A Majeed
Journal:  J Public Health (Oxf)       Date:  2014-05-05       Impact factor: 2.341

9.  Hydroxyurea stimulates the release of ATP from rabbit erythrocytes through an increase in calcium and nitric oxide production.

Authors:  Madushi Raththagala; Welivitya Karunarathne; Matthew Kryziniak; John McCracken; Dana M Spence
Journal:  Eur J Pharmacol       Date:  2010-07-23       Impact factor: 4.432

10.  Combined hydroxyurea and ETA receptor blockade reduces renal injury in the humanized sickle cell mouse.

Authors:  Crystal Taylor; Malgorzata Kasztan; Binli Tao; Jennifer S Pollock; David M Pollock
Journal:  Acta Physiol (Oxf)       Date:  2018-09-20       Impact factor: 6.311

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.